Literature DB >> 9300724

Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease.

B B Mittleman1, F X Castellanos, L K Jacobsen, J L Rapoport, S E Swedo, G M Shearer.   

Abstract

This study examines cerebrospinal fluid from patients with three neuropsychiatric diseases of childhood for the presence and levels of several cytokines relevant to cell-mediated (type 1) and humoral (type 2) immunity. The patient groups include childhood-onset schizophrenia (n = 22), obsessive-compulsive disorder (OCD) (n = 24), and attention deficit hyperactivity disorder (n = 42). The cytokines examined include IL-2, IFN-gamma, TNF-beta/LT, IL-4, IL-5, IL-10, and TNF-alpha. Patients with OCD had a preponderance of type 1 cytokines. IL-4 was detectable only in samples from patients with schizophrenia. IL-10 was rarely detected and never in patients with OCD. Few patients with schizophrenia had detectable amounts of IFN-gamma in CSFL. We conclude that there is a relative skewing of CSFL profiles toward type 1 cytokines in patients with OCD, whereas in schizophrenia the relative preponderance is toward type 2 mediators. Patients with attention deficit hyperactivity disorder exhibited profiles intermediate between OCD and schizophrenia. We infer that cell-mediated immunity may be involved in the etiopathogenesis of OCD, whereas a relative lack of cell-mediated immunity and involvement of humoral immunity may be present in schizophrenia. These data provide a rationale for immune-based strategies of study and therapeutics in childhood neuropsychiatric disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300724

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  Immune response to intrathecal enzyme replacement therapy in mucopolysaccharidosis I patients.

Authors:  Moin Vera; Steven Le; Shih-Hsin Kan; Hermes Garban; David Naylor; Anton Mlikotic; Ilkka Kaitila; Paul Harmatz; Agnes Chen; Patricia Dickson
Journal:  Pediatr Res       Date:  2013-09-03       Impact factor: 3.756

Review 2.  Systematic review of proinflammatory cytokines in obsessive-compulsive disorder.

Authors:  Simon M Gray; Michael H Bloch
Journal:  Curr Psychiatry Rep       Date:  2012-06       Impact factor: 5.285

Review 3.  [Immunology in schizophrenic disorders].

Authors:  N Müller; M J Schwarz
Journal:  Nervenarzt       Date:  2007-03       Impact factor: 1.214

Review 4.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

5.  Oxidative stress and immune aberrancies in attention-deficit/hyperactivity disorder (ADHD): a case-control comparison.

Authors:  Annelies A J Verlaet; Annelies Breynaert; Berten Ceulemans; Tess De Bruyne; Erik Fransen; Luc Pieters; Huub F J Savelkoul; Nina Hermans
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-10-22       Impact factor: 4.785

6.  Streptococcal upper respiratory tract infections and psychosocial stress predict future tic and obsessive-compulsive symptom severity in children and adolescents with Tourette syndrome and obsessive-compulsive disorder.

Authors:  Haiqun Lin; Kyle A Williams; Liliya Katsovich; Diane B Findley; Heidi Grantz; Paul J Lombroso; Robert A King; Debra E Bessen; Dwight Johnson; Edward L Kaplan; Angeli Landeros-Weisenberger; Heping Zhang; James F Leckman
Journal:  Biol Psychiatry       Date:  2009-10-14       Impact factor: 13.382

7.  Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism--effects of medication.

Authors:  Robert D Oades; Maria R Dauvermann; Benno G Schimmelmann; Markus J Schwarz; Aye-Mu Myint
Journal:  Behav Brain Funct       Date:  2010-05-28       Impact factor: 3.759

8.  Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention.

Authors:  Robert D Oades; Aye-Mu Myint; Maria R Dauvermann; Benno G Schimmelmann; Markus J Schwarz
Journal:  Behav Brain Funct       Date:  2010-06-09       Impact factor: 3.759

Review 9.  Immunopathogenic mechanisms in tourette syndrome: A critical review.

Authors:  Davide Martino; Russell C Dale; Donald L Gilbert; Gavin Giovannoni; James F Leckman
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

Review 10.  Immune-mediated animal models of Tourette syndrome.

Authors:  Mady Hornig; W Ian Lipkin
Journal:  Neurosci Biobehav Rev       Date:  2013-01-10       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.